BEMZEFTA Trademark

Trademark Overview


On Tuesday, October 17, 2017, a trademark application was filed for BEMZEFTA with the United States Patent and Trademark Office. The USPTO has given the BEMZEFTA trademark a serial number of 87648954. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 10, 2019. This trademark is owned by H. Lundbeck A/S. The BEMZEFTA trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, ...

Medical apparatus and instruments for use in diagnosing and monitoring vital signs of patients with psychiatric and neurological disorders and diseases, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; injection devices for pharmaceuticals, syringes and needles for injections and medical purposes; integrated medical systems, namely, medical diagnostic imaging apparatus and software sold as a uni...
bemzefta

General Information


Serial Number87648954
Word MarkBEMZEFTA
Filing DateTuesday, October 17, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 10, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 15, 2018

Trademark Statements


Goods and ServicesVaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, somnolence, nausea, cancer, migraine, alcoholism and dependency; diagnostic agents, reagents, preparations and substances for medical purposes; all of the foregoing goods excluding pharmaceutical preparations and substances for the treatment of autoimmune diseases and immunologic conditions
Goods and ServicesMedical apparatus and instruments for use in diagnosing and monitoring vital signs of patients with psychiatric and neurological disorders and diseases, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; injection devices for pharmaceuticals, syringes and needles for injections and medical purposes; integrated medical systems, namely, medical diagnostic imaging apparatus and software sold as a unit therewith for managing, measuring, monitoring, assessing, controlling, collecting, storing and examining patient and client data and information captured by the medical system in web-based physical, psychological and neurological examinations conducted at a distance and at a clinic; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 26, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, October 26, 2017
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameH. Lundbeck A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address2500 Valby
DK

Party NameH. Lundbeck A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address2500 Valby
DK

Trademark Events


Event DateEvent Description
Monday, June 10, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 10, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 6, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, September 23, 2018EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, July 25, 2018CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Wednesday, July 25, 2018ASSIGNED TO PETITION STAFF
Tuesday, June 26, 2018TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, May 16, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, May 15, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 15, 2018PUBLISHED FOR OPPOSITION
Wednesday, April 25, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 9, 2018ASSIGNED TO LIE
Monday, April 2, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 15, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, March 15, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 15, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, March 15, 2018EXAMINERS AMENDMENT -WRITTEN
Friday, January 19, 2018NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, January 19, 2018PRIORITY ACTION E-MAILED
Friday, January 19, 2018PRIORITY ACTION WRITTEN
Friday, January 19, 2018ASSIGNED TO EXAMINER
Thursday, October 26, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, October 20, 2017NEW APPLICATION ENTERED IN TRAM